USX:BEAT - BioTelemetry Inc (USD 43.27) BioTelemetry Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 43.27    +1.840 (+4.44%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: 1.840 (4.44%)

52 Wk Range: 27.35 - 60.4

Day's Range: 41.295 - 43.94

Last Volume: 339,689

Current Yield: 0%

Projected Yield: 0%

Open: USD 42.45

9 Apr 2020

Metric BEAT S.Median
Beta 1.3 0.84
VaR 31 25.23
E.Shortfall 43.96 45.03
Liquidity 289.22K 95.2K


9 Apr 2020

PE: 52.833

Market Cap: 1.6B

Price Over Book: 4.297

Price Over Sales: 3.59

Return On Assets: 4.4%

Return On Equity: 8.1%

Price Over NAV: [Friends Only]


CEO: Joe Capper

Headquarters: MALVERN

Employees: 1,500

Sector: Health Technology

Industry: Medical Specialties

Useful Links


BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. It offers Mobile Cardiac Outpatient Telemetry and External Cardiac Ambulatory Telemetry services, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter and extended-wear Holter monitors to cardiologists and electrophysiologists. The Research Services segment provides cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, and expert reporting and statistical analysis. This segment also offers services in the cardiovascular, oncology, musculoskeletal, and neurologic therapeutic areas; and support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Technology segment focuses on the manufacture, engineering, and development of non-invasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors. BioTelemetry, Inc. is headquartered in Malvern, Pennsylvania.